Patients have told ABC NEWS they're concerned about a lack of informed consent over Australia's most common osteoporosis drug ...

The elderly population is at risk for polypharmacy and, therefore, also at risk for drug-induced osteoporosis (DIOP). Epidemiologic studies provide valuable information about medications that may ...

The Business Research Company's Osteoporosis Drugs Global Market Report 2024 – Market Size, Trends, And Market Forecast 2024-2033 You Can Now Pre Order Your Report To Get A Swift Deliver With ...

said it was a highly effective and safe drug. He said many patients also found it far easier to tolerate than other ...

Menopause could be weakening your bones. Check out these expert tips to keep your bone health strong and prevent osteoporosis.

The Central Drugs Standard Control Organisation (CDSCO) identified 49 drugs failing quality tests in its September report.

Eladynos – which is only the second osteoporosis drug to reach UK patients in the last 15 years – could now find a role as an alternative to Evenity and Forsteo, is seen as an important ...

Consumers need to be informed and aware of the side-effects associated with using the osteoporosis drug Prolia, says Consumers Health Forum of ...

Mechanism of Action Most of the DIOP with antiepileptic medications has been associated ... in patients deemed to be at high risk for osteoporosis. Because certain antiepileptic medications ...

The FDA has rejected Amgen and UCB’s Evenity (romosozumab) osteoporosis drug after a late-stage trial unexpectedly highlighted a potential cardiac safety risk. In May, the companies unexpectedly ...